Ustekinumab 90 mg Every 2 Weeks for the Treatment of Inflammatory Bowel Disease
نویسندگان
چکیده
منابع مشابه
Application of extracellular vesicles in the treatment of inflammatory bowel disease
Introduction: Inflammatory bowel disease(IBD) is caused by genetic, environmental, microbial and immune factors. IBD has two primary forms: Ulcerative colitis and Crohn´s disease. The incidence of IBD has significantly increased over the last few decades. Given that patients have poor response to drug treatments or are resistant to drug therapies, new therapies are needed for gastrointestinal i...
متن کاملNeonatal Presentation of Unremitting Inflammatory Bowel Disease
Very-early-onset inflammatory bowel disease (VEO-IBD) has a distinct phenotype and should be considered a specific entity. VEO-IBD presents with very severe clinical pictures and is frequently known by an indeterminate colitis whose clinical remission is unmanageable. This study examines the case of a neonate with VEO-IBD, not responding to medical and surgical treatment. A 7-day-old Iranian fe...
متن کاملUstekinumab for the treatment of Crohn's disease.
Crohn's disease (CD) results from a pathological immune response to luminal antigens in genetically predisposed individuals. Since the causes of CD are complex and only partially understood, treatment is based on the empiric use of anti-inflammatory drugs. Although multiple therapies for CD currently exist, a substantial proportion of patients are unresponsive to conventional agents. Approximat...
متن کاملan overview on inflammatory bowel disease treatment
inflammatory bowel disease (ibd) is a chronic relapsing, idiopathic disorder of the gastrointestinal tract of an unknown etiology. ulcerative colitis (uc) and crohn's disease (cd) have become important health problems.â current medical therapy of ibd has advanced dramatically with the introduction of new biologic therapies in addition to the optimization of conventional therapies that include ...
متن کاملInflammatory bowel disease. 2: Medical and surgical treatment.
The first article in this three-part series reviewed the aetiology, treatment and concept of participation in inflammatory bowel disease. This article provides a brief overview of current trends in the medical and surgical treatment of inflammatory bowel disease. The discussion of medical management will include the most common drugs utilized for symptom control, their modes of action, routes o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Gastroenterology and Hepatology
سال: 2021
ISSN: 1542-3565
DOI: 10.1016/j.cgh.2020.08.002